{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:40:59Z","timestamp":1790091659188,"version":"4.0.1"},"reference-count":31,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["401821119"],"award-info":[{"award-number":["401821119"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"award":["401821119"],"award-info":[{"award-number":["401821119"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Herpesvirus infections belong to major pathogens in the human population. This study aimed at evaluating diagnostic data for eight human herpesviruses, based on datasets derived from a large European tertiary care center. Specifically, we analyzed 118,692 herpesvirus submittals to the Diagnostic Division of the Virological Institute, University Hospital Erlangen (UKER), Germany, between July 2014 and June 2024. Our points of focus were the following: (i) the frequencies of herpesvirus diagnostic results with positivity rates, (ii) departments representing main sample submitters, (iii) the specific importance of intensive care units (ICUs), (iv) the COVID-19 pandemic period, and (v) distinct properties of sample types. Overall, we are stating the highest frequencies of diagnostic assessment for herpes simplex virus (HSV), human cytomegalovirus (HCMV), and Epstein\u2013Barr virus (EBV) infections, pointing to their dominant relevance for clinical practice. Notably, HCMV submittals (46.6% of total), together with EBV (26.2%) and HSV (15.7), accounted for almost 90% of all herpesviral diagnostic samples during this period. Within these key groups, HCMV, EBV and HSV showed positivity rates of 14.5%, 35.0%, and 18.5%, respectively. Concerning a main input of sample submittals, two departments were predominant in our center, i.e., the Departments of Haematology\u2013Oncology and Anaesthesiology. These included patients under multifold types of treatment associated with an increased risk of herpesvirus reactivation or primary infection. Furthermore, another high portion of submittals was noted for ICUs and external sources. In addition, a numerical, transient increase in herpesvirus diagnostic submittals, from various sources, was shown for the COVID-19 pandemic years (mostly 2021) as compared to other periods. Combined, these data underlined the importance of clinical monitoring of herpesvirus infections, particularly for high-risk patients, and the steady need of improvements in preventive measures, therapeutic options, and safe diagnostic tools.<\/jats:p>","DOI":"10.3390\/pathogens15060631","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:46:28Z","timestamp":1781588788000},"page":"631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Current Status of Herpesviridae as Major Human Pathogens: A 10-Year Diagnostic Evaluation in Germany"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0617-5063","authenticated-orcid":false,"given":"Lucio","family":"Fortelny","sequence":"first","affiliation":[{"name":"Harald zur Hausen Institute of Virology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[{"name":"Harald zur Hausen Institute of Virology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12985-025-02795-7","article-title":"Herpesvirus-associated diseases: Biomarkers and advancements in clinical research","volume":"22","author":"Lu","year":"2025","journal-title":"Virol. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43556-024-00199-7","article-title":"A review of HSV pathogenesis, vaccine development, and advanced applications","volume":"5","author":"Bai","year":"2024","journal-title":"Mol. Biomed."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kennedy, P.G.E., and Gershon, A.A. (2018). Clinical Features of Varicella-Zoster Virus Infection. Viruses, 10.","DOI":"10.3390\/v10110609"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2014-1173","article-title":"Hearing Loss and Congenital CMV Infection: A Systematic Review","volume":"134","author":"Goderis","year":"2014","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","first-page":"45","article-title":"Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy","volume":"114","author":"Buxmann","year":"2017","journal-title":"Dtsch. \u00c4rzteblatt Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"22766","DOI":"10.3402\/jom.v5i0.22766","article-title":"Herpesviruses: Latency and reactivation\u2014Viral strategies and host response","volume":"5","author":"Grinde","year":"2013","journal-title":"J. Oral Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","article-title":"Antiviral Therapies for Herpesviruses: Current Agents and New Directions","volume":"40","author":"Poole","year":"2018","journal-title":"Clin. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Williams, L.R., Hombach, J., and Marti, M. (2025). Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy. Vaccines, 13.","DOI":"10.3390\/vaccines13030250"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.vaccine.2023.06.020","article-title":"Vaccine value profile for cytomegalovirus","volume":"41","author":"Boppana","year":"2023","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dai, Y., Zhang, B., Yang, L., Tao, S., Yu, Y., and Li, C. (2025). Recent Progress in the Vaccine Development Against Epstein\u2013Barr Virus. Viruses, 17.","DOI":"10.3390\/v17070936"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kim, H.H., Jang, S.H., Han, J.S., Jeon, J.-S., and Kim, J.K. (2025). Epidemiological Characteristics of HSV-1 and HSV-2 in 177,599 Patients Based on PCR Testing in South Korea (2018\u20132022). Pathogens, 14.","DOI":"10.3390\/pathogens14111107"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/23744235.2024.2365906","article-title":"Seroprevalence of human herpes viruses in France, 2018\u20132022: A multilevel regression and poststratification approach","volume":"56","author":"Supplisson","year":"2024","journal-title":"Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wei, M., Zhang, Y., Li, Z., Liang, Q., Cao, T., and Ma, J. (2024). Epidemiological characteristics of three herpesviruses infections in children in Nanjing, China, from 2018 to 2023. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1448533"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10096-020-03814-x","article-title":"Thirty years of CMV seroprevalence\u2014A longitudinal analysis in a German university hospital","volume":"39","author":"Hoehl","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_16","unstructured":"Howley, P.M., Knipe, D.M., Damania, B.A., and Cohen, J.I. (2022). Fields Virology: DNA Viruses, 7e, Lippincott Williams & Wilkins."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1469-0691.2007.01895.x","article-title":"Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy","volume":"14","author":"Kuo","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in Solid Organ Transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, H., Zhao, S., and Cao, Z. (2022). Impact of Epstein\u2013Barr virus infection in patients with inflammatory bowel disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1001055"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cix120","article-title":"Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock","volume":"64","author":"Ong","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ofx029","DOI":"10.1093\/ofid\/ofx029","article-title":"Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis","volume":"4","author":"Lachance","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432.e1","DOI":"10.1016\/j.jcrc.2010.10.008","article-title":"Herpes simplex virus: A marker of severity in bacterial ventilator-associated pneumonia","volume":"26","author":"Bouza","year":"2011","journal-title":"J. Crit. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1002\/jmv.27994","article-title":"SARS-CoV-2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?","volume":"94","author":"Chen","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e29849","DOI":"10.1002\/jmv.29849","article-title":"Exploring the interplay between Kaposi\u2019s sarcoma and SARS-CoV-2 infection: A case series and systematic review","volume":"96","author":"Pietroluongo","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1469-0691.2009.02704.x","article-title":"Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: A prospective study","volume":"15","author":"Vankeerberghen","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(03)14740-X","article-title":"Herpes simplex virus in the respiratory tract of critical care patients: A prospective study","volume":"362","author":"Bruynseels","year":"2003","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00134-024-07345-3","article-title":"Reactivation of Epstein\u2013Barr virus among intensive care patients: A prospective observational study","volume":"50","author":"Guiouillier","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1038\/s41598-020-66713-3","article-title":"Epstein-Barr virus reactivation in sepsis due to community-acquired pneumonia is associated with increased morbidity and an immunosuppressed host transcriptomic endotype","volume":"10","author":"Goh","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3810\/pgm.2013.09.2703","article-title":"Herpes Zoster: Diagnostic, Therapeutic, and Preventive Approaches","volume":"125","author":"Bader","year":"2013","journal-title":"Postgrad. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coviro.2014.09.006","article-title":"Roseoloviruses in transplant recipients: Clinical consequences and prospects for treatment and prevention trials","volume":"9","author":"Hill","year":"2014","journal-title":"Curr. Opin. Virol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/6\/631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:15:19Z","timestamp":1781842519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/6\/631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["pathogens15060631"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15060631","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]}}}